Wellgistics Health Halts Future Share Issuance by Terminating Silverback Settlement
Summary
Wellgistics Health has terminated its Section 3(a)(10) Settlement Agreement with Silverback Capital, effective April 3, 2026, preventing any further share issuance under this specific arrangement. This move, disclosed today, aims to eliminate potential future dilution and allows the company to pursue alternative financing initiatives. While 6,866,000 shares were issued prior to termination, halting additional issuance is a positive development for existing shareholders, especially given the company's severe financial distress, including a going concern warning and recent highly dilutive promissory note financing. This indicates a strategic shift to better manage its capital structure amidst ongoing efforts to address Nasdaq delisting concerns and secure funding.
At the time of this announcement, WGRX was trading at $0.13 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $11.1M. The 52-week trading range was $0.10 to $7.04. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.